DUPONT CAPITAL MANAGEMENT CORP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$83,000
-63.3%
8,616
+77.0%
0.01%0.0%
Q4 2020$226,000
+41.2%
4,8690.0%0.01%
+25.0%
Q3 2020$160,000
-70.3%
4,869
-75.2%
0.00%
-66.7%
Q2 2020$539,000
-10.5%
19,627
-2.5%
0.01%
-14.3%
Q1 2020$602,000
-14.6%
20,121
-21.0%
0.01%
-12.5%
Q4 2019$705,000
+95.8%
25,473
-32.7%
0.02%
+100.0%
Q1 2019$360,000
+7.5%
37,8700.0%0.01%0.0%
Q4 2018$335,000
+6.7%
37,870
+35.6%
0.01%
+14.3%
Q3 2018$314,00027,9370.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,674,299$65,948,0005.28%
Ghost Tree Capital, LLC 700,000$17,262,0005.05%
Perceptive Advisors 11,489,772$283,337,0004.12%
Prosight Management, LP 274,761$6,776,0003.73%
Fairmount Funds Management LLC 389,588$9,607,0003.49%
Avoro Capital Advisors LLC 8,500,000$209,610,0003.29%
ACUTA CAPITAL PARTNERS, LLC 374,495$9,235,0003.26%
Ally Bridge Group (NY) LLC 406,986$10,036,0002.95%
Parametrica Management Ltd 146,362$3,609,0002.70%
COMMODORE CAPITAL LP 362,869$8,948,0002.36%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders